Semler Scientific (NASDAQ:SMLR) & Vasamed (OTCMKTS:VSMD) Head-To-Head Survey

Semler Scientific (NASDAQ:SMLR) and Vasamed (OTCMKTS:VSMD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Earnings & Valuation

This table compares Semler Scientific and Vasamed”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Semler Scientific	$56.29 million	4.72	$40.90 million	$2.78	6.26
Vasamed	N/A	N/A	N/A	N/A	N/A

Semler Scientific has higher revenue and earnings than Vasamed.

Analyst Ratings

This is a summary of current ratings and recommmendations for Semler Scientific and Vasamed, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Semler Scientific	0	1	4	0	2.80
Vasamed	0	0	0	0	0.00

Semler Scientific presently has a consensus price target of $74.25, suggesting a potential upside of 326.72%. Given Semler Scientific’s stronger consensus rating and higher probable upside, equities analysts clearly believe Semler Scientific is more favorable than Vasamed.

Profitability

This table compares Semler Scientific and Vasamed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Semler Scientific	130.80%	34.21%	25.58%
Vasamed	N/A	N/A	N/A

Institutional and Insider Ownership

49.4% of Semler Scientific shares are owned by institutional investors. 16.4% of Semler Scientific shares are owned by company insiders. Comparatively, 8.0% of Vasamed shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Semler Scientific beats Vasamed on 9 of the 9 factors compared between the two stocks.

About Semler Scientific

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

About Vasamed

Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. It offers SensiLase PAD-IQ, which supports skin perfusion pressure, pulse volume recording, and ankle brachial index calculation for Doppler-obtained pressures; and Wound Imaging & SmartDraw wound measurement systems. The company also provides PAD-IQ Studycast that provides rapid transmission of diagnostic tests to vascular specialist for interpretation of results and medically indicated therapeutic intervention; and custom carrying case to secure and protect the PAD-IQ system. It serves clinicians and patients. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota.